Showing results (31-40 of 43) with videos related to

Sort By:
Pageof 5
Oncotarget|July 15, 2015
Growth arrest DNA damage-inducible gene 45 gamma expression as a prognostic and predictive biomarker in hepatocellular carcinomaDa-Liang Ou, Song-Kun Shyue, Liang-In Lin, et al.
Journal for Immunotherapy of Cancer|March 23, 2021
Regorafenib enhances antitumor immunity via inhibition of p38 kinase/Creb1/Klf4 axis in tumor-associated macrophagesDa-Liang Ou, Chia-Wei Chen, Chia-Lang Hsu, et al.
International Journal of Nanomedicine|December 9, 2025
Local M1 Macrophage Reprogramming with Gluconic Acid-Coated Selenium NanoparticlesZi-Xian Liao, Da-Liang Ou, Chia-Lang Hsu, et al.
Cancer Letters|April 10, 2016
Cabozantinib is selectively cytotoxic in acute myeloid leukemia cells with FLT3-internal tandem duplication (FLT3-ITD)Jeng-Wei Lu, An-Ni Wang, Heng-An Liao, et al.
Plos One|December 5, 2012
KRAS mutation is a predictor of oxaliplatin sensitivity in colon cancer cellsYu-Lin Lin, Jau-Yu Liau, Shan-Chi Yu, et al.
Liver Cancer|June 14, 2019
Development of a PD-L1-Expressing Orthotopic Liver Cancer Model: Implications for Immunotherapy for Hepatocellular CarcinomaDa-Liang Ou, Yu-Yang Lin, Chia-Lang Hsu, et al.
Journal of Gastroenterology and Hepatology|August 28, 2014
Potential synergistic anti-tumor activity between lenalidomide and sorafenib in hepatocellular carcinomaDa-Liang Ou, Chun-Jung Chang, Yung-Ming Jeng, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 10, 2009
Induction of Bim expression contributes to the antitumor synergy between sorafenib and mitogen-activated protein kinase/extracellular signal-regulated kinase kinase inhibitor CI-1040 in hepatocellular carcinomaDa-Liang Ou, Ying-Chun Shen, Ja-Der Liang, et al.
Life Sciences|January 14, 2026
Cabozantinib induces NLRP3-CASP1-GSDMD-dependent pyroptosis in hepatocellular carcinomaLi Lin, Chiun Hsu, Chia-Lang Hsu, et al.
Cancer Gene Therapy|June 12, 2021
Cabozantinib promotes erythroid differentiation in K562 erythroleukemia cells through global changes in gene expression and JNK activationYu-Hsuan Fu, Da-Liang Ou, Yi-Ru Yang, et al.
Pageof 5